Zim Laboratories Limited — Others, 03-06-2025: Shareholders meeting

ZIM Laboratories Limited has announced a board meeting to consider the financial results for the quarter and half-year and to hold its 41st Annual General Meeting via video conferencing. The company plans to reappoint Mr. Zulfiquar Kamal as Whole-time Director and appoint M/s. Deloitte Haskins & Sells LLP as new Statutory Auditors for five years. It will ratify Cost Auditors’ remuneration and appoint M/s. BNP & Associates as Secretarial Auditors for five years. Special resolutions include reappointing Dr. Kamlesh Shende and appointing Mr. Ashok Bhatia as Independent Directors with approved remuneration. Consolidated revenue stood at ₹379 Cr with net profit of ₹12.16 Cr. Investments are ongoing in R&D, manufacturing expansion, and global market growth. CSR initiatives in healthcare, education, women empowerment, and environment had an outlay of ₹48.53 Lakhs for FY25. Fraud risk management and governance remain priority areas.